INSIGHTS ON LIQUID DOSE MANUFACTURING

• SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds

  Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

• Afton Scientific Capabilities Update January 2026: Fill/Finish

  Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

• Expanding Subcutaneous Design Brick By Brick

  Biologics are growing more complex. But what if the syringe itself could unlock new possibilities? Discover the technology “bricks” quietly reshaping subcutaneous drug delivery.

• Unlock Large-Volume Drug Delivery With Vertiva® On-Body Delivery System

  See a large-volume drug delivery with a pre-filled, pre-loaded on-body device. Its programmable dosing profiles and reusable controller offer sustainable treatment while minimizing patient use errors.

• Preparing Global Parenteral Sites For Annex 1 Compliance

  9/1/2026

  Modern sterile manufacturing requires proactive quality risk management. Robust contamination control across facilities, processes, and supply chains supports compliance and patient safety.

• The Clear Solution: Navigating Contamination Control For Ophthalmic Injectables

  8/12/2026

  As the intravitreal therapy market grows and applicable regulations evolve, continued compliance demands technological savvy and rigorous contamination control.

• Commercially Proven Sterile Fill/Finish With Capacity And Global Backing

  1/27/2026

  Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.

• Design Verification Done Right: Smarter Strategies For Prefillable Syringes

  9/29/2026

  A practical framework for planning and justifying design verification programs for prefillable syringes, covering test selection, acceptance criteria, and sample-size rationale within a risk-based approach.

• Cost-Effective Strategies For Sterile Injectable Outsourcing

  6/11/2025

  Explore how CMOs are playing a pivotal role in enabling pharmaceutical companies to optimize their operations and how this collaboration is reshaping the future of pharmaceutical manufacturing.